ClearPoint Neuro, Inc.
CLPT · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $416 | $167 | $205 | $233 |
| - Cash | $20 | $23 | $28 | $54 |
| + Debt | $4 | $14 | $12 | $12 |
| Enterprise Value | $399 | $158 | $189 | $191 |
| Revenue | $31 | $24 | $21 | $16 |
| % Growth | 31% | 16.6% | 26.1% | – |
| Gross Profit | $19 | $14 | $14 | $11 |
| % Margin | 60.9% | 56.8% | 65.8% | 68.2% |
| EBITDA | -$18 | -$21 | -$16 | -$13 |
| % Margin | -56.8% | -87.6% | -75.8% | -78.2% |
| Net Income | -$19 | -$22 | -$16 | -$14 |
| % Margin | -60.3% | -92.2% | -80% | -88.4% |
| EPS Diluted | -0.7 | -0.9 | -0.68 | -0.69 |
| % Growth | 22.2% | -32.4% | 1.4% | – |
| Operating Cash Flow | -$9 | -$14 | -$16 | -$13 |
| Capital Expenditures | -$0 | -$1 | -$0 | -$0 |
| Free Cash Flow | -$9 | -$14 | -$16 | -$13 |